These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7683401)

  • 1. DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P, and substance P fragments.
    Krumins SA; Kim DC; Igwe OJ; Larson AA
    Peptides; 1993; 14(2):309-14. PubMed ID: 7683401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice.
    Krumins SA; Kim DC; Larson AA
    Peptides; 1990; 11(2):281-5. PubMed ID: 1694028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanine nucleotide regulation of [125I]beta-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements.
    Selley DE; Bidlack JM
    Brain Res; 1989 Jul; 493(1):23-32. PubMed ID: 2550106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions.
    Krumins SA; Kim DC; Seybold VS; Larson AA
    Neuropeptides; 1989; 13(4):225-33. PubMed ID: 2473408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from 7315c cell membranes.
    Cote TE; Gosse ME; Weems HB
    J Neurochem; 1993 Sep; 61(3):973-8. PubMed ID: 8395567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.
    Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Kayakiri H; Rothman RB
    Peptides; 1995; 16(6):1083-95. PubMed ID: 8532593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.
    Fox AJ; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes.
    Igwe OJ; Kim DC; Seybold VS; Larson AA
    J Neurosci; 1990 Nov; 10(11):3653-63. PubMed ID: 1700082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny and distribution of opioid receptors in the rat brainstem.
    Xia Y; Haddad GG
    Brain Res; 1991 May; 549(2):181-93. PubMed ID: 1653081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an involvement of the mu-type of opioid receptor in the modulation of learning.
    Aloyo VJ; Romano AG; Harvey JA
    Neuroscience; 1993 Jul; 55(2):511-9. PubMed ID: 8397346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.